K. Watt, E. Waddle, and R. Jhaveri, Changing epidemiology of serious bacterial infections in febrile infants without localizing signs, PloS one, vol.5, issue.8, p.12448, 2010.

C. H. Cheng, M. H. Tsai, L. H. Su, C. R. Wang, W. C. Lo et al., Renal abscess in children: a 10-year clinical and radiologic experience in a tertiary medical center, Pediatric Infectious Diseases Journal, vol.27, issue.11, pp.1025-1032, 2008.

A. Hoberman, M. Charron, R. W. Hickey, M. Baskin, D. H. Kearney et al., Imaging studies after a first febrile urinary tract infection in young children, New England Journal of Medicine, vol.348, issue.3, pp.195-202, 2003.

N. Shaikh, A. L. Ewing, S. Bhatnagar, and A. Hoberman, Risk of renal scarring in children with a first urinary tract infection: a systematic review, Pediatrics, vol.126, issue.6, pp.1084-91, 2010.

N. Shaikh, T. K. Mattoo, R. Keren, A. Ivanova, G. Cui et al., Early Antibiotic Treatment for Pediatric Febrile Urinary Tract Infection and Renal Scarring, JAMA Pediatrics, vol.170, issue.9, pp.848-54, 2016.

. Who and . Resistance, Global report on surveillance, 2014.

L. K. Logan, A. M. Hujer, S. H. Marshall, T. N. Domitrovic, S. D. Rudin et al., Analysis of betaLactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter Survey, Antimicrobial agents and chemotherapy, vol.60, issue.6, pp.3462-3471, 2016.

L. K. Logan, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.55, pp.852-861, 2012.

P. J. Lukac, R. A. Bonomo, and L. K. Logan, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.60, pp.1389-97, 2015.

M. E. Falagas, D. E. Karageorgopoulos, and P. Nordmann, Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes, Future Microbiology, vol.6, issue.6, pp.653-66, 2011.

A. J. Hsu and P. D. Tamma, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.58, pp.1439-1487, 2014.

. Fda and . Fda, Drug Safety Podcast: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning, 2013.

G. Raman, E. Avendano, S. Berger, and V. Menon, Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis, BMC Infectious Diseases, vol.15, p.395, 2015.

A. L. Freedman, Urologic Diseases in America P. Urologic diseases in North America Project: trends in resource utilization for urinary tract infections in children, Journal of Urology, vol.173, issue.3, pp.949-54, 2005.

R. Basmaci, K. Vazouras, J. Bielicki, L. Folgori, Y. Hsia et al., Urinary Tract Infection Antibiotic Trial Study Design: A Systematic Review, Pediatrics, vol.140, issue.6, 2017.

D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and P. Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS medicine, vol.6, issue.7, p.1000097, 2009.

M. Freeman and J. W. Tukey, Transformations related to the angular and the square root, The Annals of Mathematical Statistics, vol.21, pp.607-618, 1950.

J. J. Miller, Inverse of Freeman-Tukey Double Arcsine Transformation, American Statistician, vol.32, issue.4, p.138, 1978.

J. P. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, Measuring inconsistency in meta-analyses, British Medical Journal, vol.327, issue.7414, pp.557-60, 2003.

J. P. Higgins, D. G. Altman, P. C. Gotzsche, P. Juni, D. Moher et al., The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, British Medical Journal, vol.343, p.5928, 2011.

Z. Allameh, A. Karimi, S. R. Tabatabaei, M. Sharifian, and J. Salamzadeh, Effect of n-acetylcysteine on inflammation biomarkers in pediatric acute pyelonephritis: A randomized controlled trial, Iranian Journal of Kidney Diseases, vol.9, issue.6, pp.454-62, 2015.

P. C. Baker, D. S. Nelson, and J. E. Schunk, The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections, Archives of Pediatrics and Adolescent Medicine, vol.155, issue.2, pp.135-144, 2001.

A. Bakkaloglu, U. Saatci, O. Soylemezoglu, S. Ozen, R. Topaloglu et al., Comparison of ceftriaxone versus cefotaxime for childhood upper urinary tract infections, Journal of Chemotherapy, vol.8, issue.1, pp.59-62, 1996.

P. Begue, J. Astruc, P. Francois, and D. Floret, Comparison of ceftriaxone and cefotaxime in severe pediatric bacterial infection: A multicentric study

, Medecine et Maladies Infectieuses, vol.28, issue.4, pp.300-306, 1998.

D. Benador, T. J. Neuhaus, J. P. Papazyan, U. V. Willi, I. Engel-bicik et al., Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring, Archives of disease in childhood, vol.84, issue.3, pp.241-246, 2001.

N. Bocquet, A. Sergent-alaoui, J. P. Jais, V. Gajdos, V. Guigonis et al., Randomized trial of oral versus sequential intravenous/oral antibiotic for acute pyelonephritis in children

, Pediatrics, vol.129, issue.2, pp.269-75, 2012.

J. R. Carapetis, A. L. Jaquiery, J. P. Buttery, M. Starr, N. E. Cranswick et al., Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections, Pediatric Infectious Diseases Journal, vol.20, issue.3, pp.240-246, 2001.

C. H. Cheng, Y. K. Tsau, and T. Y. Lin, Effective duration of antimicrobial therapy for the treatment of acute lobar nephronia, Pediatrics, vol.117, issue.1, 2006.

C. Y. Chong, A. Tan, W. Ng, A. Tan-kendrick, A. Balakrishnan et al., Treatment of urinary tract infection with gentamicin once or three times daily, International Journal of Paediatrics, vol.92, issue.3, pp.291-297, 2003.

R. Dagan, M. Einhorn, R. Lang, A. Pomeranz, B. Wolach et al., Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children, Pediatric Infectious Diseases Journal, vol.11, issue.3, pp.198-203, 1992.

P. Francois, A. Bensman, P. Begue, M. A. Artaz, L. Coudeville et al., Assessment of the efficacy and cost efficiency of two strategies in the treatment of acute pyelonephritis in children: Oral cefixime or parenteral ceftriaxone after an initial IV combination therapy

, Medecine et Maladies Infectieuses, vol.27, pp.667-73, 1997.

F. Gok, A. Duzova, E. Baskin, S. Ozen, N. Besbas et al., Comparative study of cefixime alone versus intramuscular ceftizoxime followed by cefixime in the treatment of urinary tract infections in children, Journal of Chemotherapy, vol.13, issue.3, pp.277-80, 2001.

Y. Y. Huang, M. J. Chen, N. T. Chiu, H. H. Chou, K. Y. Lin et al., Adjunctive oral methylprednisolone in pediatric acute pyelonephritis alleviates renal scarring, Pediatrics, vol.128, issue.3, 2011.

D. A. Kafetzis, H. C. Maltezou, M. Mavrikou, C. Siafas, I. Paraskakis et al., Isepamicin versus amikacin for the treatment of acute pyelonephritis in children, International journal of antimicrobial agents, vol.14, issue.1, pp.51-55, 2000.

E. Levtchenko, C. Lahy, J. Levy, H. Ham, and A. Piepsz, Treatment of children with acute pyelonephritis: A prospective randomized study, Pediatric Nephrology, vol.16, issue.11, pp.878-84, 2001.

S. Marild, U. Jodal, and T. Sandberg, Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children, Pediatric Nephrology, vol.24, issue.3, pp.521-527, 2009.

G. Montini, A. Toffolo, P. Zucchetta, R. Dall'amico, D. Gobber et al., Antibiotic treatment for pyelonephritis in children: Multicentre randomised controlled non-inferiority trial, British Medical Journal, vol.335, issue.7616, pp.386-394, 2007.

T. J. Neuhaus, C. Berger, K. Buechner, P. Parvex, G. Bischoff et al., Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritis, European journal of pediatrics, vol.167, issue.9, pp.1037-1047, 2008.

S. Noorbakhsh, A. R. Lari, F. Masjedian, H. Mostafavi, and R. Alaghehbandan, Comparison of intravenous aminoglycoside therapy with switch therapy to cefixime in urinary tract infections, Saudi Medical Journal, vol.25, issue.10, pp.1513-1518, 2004.

D. A. Pena, S. T. Viviani, P. N. Le-corre, M. V. Morales, B. C. Montecinos et al., Treatment of urinary tract infections in febrile infants: Experience of outpatient intravenous antibiotic treatment

, Revista Chilena de Infectologia, vol.26, issue.4, pp.350-354, 2009.

U. B. Schaad, J. Eskola, D. Kafetzis, M. Fishbach, S. Ashkenazi et al., Cefepime vs. ceftazidime treatment of pyelonephritis: A European, randomized, controlled study of 300 pediatric cases, Pediatric Infectious Diseases Journal, vol.17, issue.7, pp.639-683, 1998.

B. Sobouti, N. Hooman, and M. Movahed, The effect of vitamin E or vitamin A on the prevention of renal scarring in children with acute pyelonephritis, Pediatric nephrology, vol.28, issue.2, pp.277-283, 2013.

C. Tapaneya-olarn, W. Tapaneya-olarn, V. Pitayamornwong, T. Petchthong, and K. Tangnararatchakit, Single daily dose of gentamicin in the treatment of pediatric urinary tract infection, Journal of the Medical Association of Thailand, vol.82, issue.1, pp.93-100, 1999.

J. Toporovski, L. Steffens, M. Noack, A. Kranz, A. Burdeska et al., Effectiveness of cefetamet pivoxil in the treatment of pyelonephritis in children, Journal of International Medical Research, vol.20, issue.1, pp.87-93, 1992.

A. Vigano and N. Principi, Aminoglycosides in paediatric infections: The role of isepamicin

, Clinical Drug Investigation, vol.12, issue.1, pp.37-46, 1996.

A. Vigano, N. Principi, L. Brivio, P. Tommasi, P. Stasi et al., Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children, Antimicrobial Agents & Chemotherapy, vol.36, issue.7, pp.1499-503, 1992.

A. Vilaichone, D. Watana, and T. Chaiwatanarat, Oral ceftibuten switch therapy for acute pyelonephritis in children, Journal of the Medical Association of Thailand = Chotmaihet thangphaet, vol.84, issue.1, pp.61-67, 2001.

P. Yosefichaijan, M. Khabazi, A. Pakniyat, and . Goudarzi, Therapeutic effect of complementary Vitamin C on pediatrics urinary tract infection, Pediatric Nephrology, vol.31, issue.10, p.1796, 2016.

P. Yousefichaijan, M. Kahbazi, S. Rasti, M. Rafeie, and M. Sharafkhah, Vitamin E as adjuvant treatment for urinary tract infection in girls with acute pyelonephritis, Iranian Journal of Kidney Diseases, vol.9, issue.2, pp.97-104, 2015.

P. Yousefichaijan, M. Naziri, H. Taherahmadi, M. Kahbazi, and A. Tabaei, Zinc supplementation in treatment of children with urinary tract infection, Iranian Journal of Kidney Diseases, vol.10, issue.4, pp.213-219, 2016.

A. Hoberman, E. R. Wald, R. W. Hickey, M. Baskin, M. Charron et al., Oral versus initial intravenous therapy for urinary tract infections in young febrile children, Pediatrics, vol.104, pp.79-86, 1999.

W. Morello, L. Scola, C. Alberici, I. Montini, and G. , Acute pyelonephritis in children, Pediatric Nephrology, vol.31, issue.8, pp.1253-65, 2016.

J. Larcombe, Urinary tract infection in children, British Medical Journal, vol.319, issue.7218, pp.1173-1178, 1999.

B. Becknell, M. Schober, L. Korbel, and J. D. Spencer, The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections, Expert Review of Anti-Infective Therapy, vol.13, issue.1, pp.81-90, 2015.

K. G. Kyriakidou, P. Rafailidis, D. K. Matthaiou, S. Athanasiou, and M. E. Falagas, Short-versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials, Clinical Therapeutics, vol.30, issue.10, pp.1859-68, 2008.

S. Finnell, Urinary tract infection in children: An update, Open Urology and Nephrology Journal, vol.8, pp.92-97, 2015.

Y. Strohmeier, E. M. Hodson, N. S. Willis, A. C. Webster, and J. C. Craig, Antibiotics for acute pyelonephritis in children. The Cochrane database of systematic reviews, vol.7, p.3772, 2014.

H. Jeffrey, Are oral antibiotics equivalent to intravenous antibiotics for the initial management of pyelonephritis in children? Paediatrics and Child Health, vol.15, pp.150-152, 2010.

E. K. Vouloumanou, P. I. Rafailidis, M. S. Kazantzi, S. Athanasiou, and M. E. Falagas, Early switch to oral versus intravenous antimicrobial treatment for hospitalized patients with acute pyelonephritis: a systematic review of randomized controlled trials, Current Medical Research & Opinion, vol.24, issue.12, pp.3423-3457, 2008.

B. Lee, S. Y. Kang, H. M. Kang, N. R. Yang, H. G. Kang et al., Outcome of Antimicrobial Therapy of Pediatric Urinary Tract Infections Caused by Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae, Infection & chemotherapy, vol.45, issue.4, pp.415-436, 2013.

N. Dalgic, M. Sancar, B. Bayraktar, E. Dincer, and S. Pelit, Ertapenem for the treatment of urinary tract infections caused by extended-spectrum beta-lactamase-producing bacteria in children, Scandinavian journal of infectious diseases, vol.43, issue.5, pp.339-382, 2011.

U. I. Wu, W. C. Chen, C. S. Yang, J. L. Wang, F. C. Hu et al., Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, vol.16, pp.47-52, 2012.

V. L. Collins, D. Marchaim, J. M. Pogue, J. Moshos, S. Bheemreddy et al., Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-beta-lactamaseproducing Enterobacteriaceae, Antimicrobial agents and chemotherapy, vol.56, issue.4, pp.2173-2180, 2012.

R. Dersimonian and N. Laird, Meta-analysis in clinical trials, Controlled clinical trials, vol.7, issue.3, pp.177-88, 1986.

K. P. Singh, G. Li, F. S. Mitrani-gold, M. Kurtinecz, J. Wetherington et al., Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection, Antimicrobial agents and chemotherapy, vol.57, issue.11, pp.5284-90, 2013.

, Guidance for industry. Complicated urinary tract infections and pyelonephritis: developing antimicrobial drugs for treatment. Draft guidance, 1998.

K. Vazouras, R. Basmaci, J. Bielicki, L. Folgori, and T. Zaoutis, Antibiotics and Cure Rates in Childhood Febrile Urinary Tract Infections in Clinical Trials: A Systematic Review and Meta-analysis, Drugs, p.2129846, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02129846